← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2018Last known activity
Jul 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 3 trials)
Phase 3 (4 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT05594342Lead sponsorPhase 3Jul 1, 2022
- NCT05594342Reponsible party - principal investigatorPhase 3Jul 1, 2022
- NCT03926780Lead sponsorPhase 3Dec 1, 2018
- NCT03926780Reponsible party - principal investigatorPhase 3Dec 1, 2018
- NCT03893435Lead sponsorN/ADec 1, 2018
- NCT03893435Reponsible party - principal investigatorN/ADec 1, 2018
Details
- Last known activity
- Jul 1, 2022